The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review
- 24 March 2022
- journal article
- review article
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 122 (4) , 871-880
Abstract
Despite a dramatic increase in treatment options over the past 30 years, Carbamazepine (CBZ) is still considered the standard of care and the most prescribed initial treatment for focal epilepsy. Hence, the identification of genetic biomarkers that influence the response, resistance and toxicity to CBZ remains a challenge. Several research studies have looked into this to highlight the polymorphisms responsible for the variability in the response to CBZ in patients with epilepsy. The aim of this review is to compare the different results published in the literature The systematic review included thirty-nine studies (2005–2021), Meta-analyses were performed on more than twelve polymorphisms in three genes (ABCB1, ABCC2, RALBP1) involved in CBZ cell transport. The current challenges are to identify other new biomarkers of antiepileptic drugs that can only materialize with large-scale collaborative research efforts.Keywords
This publication has 74 references indexed in Scilit:
- Linkage Disequilibrium between Polymorphisms of ABCB1 and ABCC2 to Predict the Treatment Outcome of Malaysians with Complex Partial Seizures on Treatment with Carbamazepine Mono-Therapy at the Kuala Lumpur HospitalPLOS ONE, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine DosingClinical Pharmacology & Therapeutics, 2013
- Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animalsIndian Journal of Pharmacology, 2013
- Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patientsBiochimie, 2010
- A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsyPharmacogenetics and Genomics, 2010
- Lack of Support for a Role for RLIP76 (RALBP1) in Response to Treatment or Predisposition to EpilepsyEpilepsia, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistancePharmacogenetics and Genomics, 2006
- Inhibition of the Multidrug Transporter P‐Glycoprotein Improves Seizure Control in Phenytoin‐treated Chronic Epileptic RatsEpilepsia, 2006
- Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transportBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995